Team

Partner

Dr Dirk Bühler

Partner

German Patent Attorney

European Patent Attorney

Biochemist

Dirk specializes in the management of product-related patent portfolios worldwide as well as the associated opposition, nullity and infringement proceedings in the fields of pharmaceuticals, biotechnology and personalized therapy and diagnostics. He regularly advises clients on complex SPC matters and freedom-to-operate strategies in these areas.

Dirk has received numerous awards for his professional activities as patent attorney and regularly publishes articles on various aspects of patent law.

since 2007
Partner, shareholder and managing director at Maiwald
since 2004
Patent attorney at Maiwald
2001 - 2004
Patent attorney trainee at Maiwald

2004
Admitted to practice as European patent attorney
2004
Admitted to practice as German patent attorney
2001 - 2004
Studied law for patent attorneys at the University of Hagen
1998 - 2001
Doctoral degree in the field of biochemistry from the Freie Universität Berlin (doctoral research at the Max Planck Institute for Biochemistry)
1992 - 1998
Studied biochemistry at the Freie Universität Berlin, the University of California, Berkeley and Heidelberg University

  • Complex patent portfolio management and patent prosecution
  • Opposition, appeal and nullity proceedings
  • Patent infringement proceedings
  • Supplementary protection certificates proceedings
  • Freedom-to-operate and validity analysis
  • Strategic consulting for biotech start-up companies

  • "Highly recommended attorney" in JUVE Patent Rankings Germany 2021, 2022
  • Ranked as "Excellent" in the Leaders League Rankings Germany 2022 in the category Patent Prosecution and recommended in the categorie Patent Litigation
  • MIP IP Star 2016, 2017, 2018, 2019, 2020, 2021, 2022
  • Recommended in Handelsblatt | Best Lawyers „Deutschlands Beste Anwälte" 2022
  • Ranked in Managing IP's EMEA 2022 shortlist
  • Listed in the WirtschaftsWoche "Die renomiertesten Patentrechtsanwälte" 2020
  • „Frequently Recommended Attorney“ in JUVE German Commercial Law Firms 2018/2019, 2019/2020, 2020/2021, 2021/2022
  • Recommended in Legal 500 EMEA 2019, 2020, 2021, 2022
  • Recommended in Legal 500 Deutschland 2016, 2017, 2019, 2020, 2021, 2022
  • For many years listed in IAM Patent 1000 “World’s Leading Patent Professionals”
  • Doctoral scholarship of the Boehringer Ingelheim Fund
  • Scholarship of the “Studienstiftung des Deutschen Volkes”

  • Representation in opposition appeal proceedings leading to the BGH X ZB 8/12 „Dipeptidyl-Peptidase-Inhibitors“ decision
  • Representation in SPC application proceedings before the ECJ in case C-650/17 (Royalty Pharma/Sitagliptin)
  • Representation in infringement proceedings concerning non-invasive prenatal diagnostics (EP 0 994 963)
  • Attending to patent portfolios, opposition and appeal proceedings before the European Patent Office as well as participation in various infringement proceedings, inter alia concerning Oxygesic®, Tramundin®, and Targin®

  • German Patent Attorney Association
  • epi
  • GBM
  • GRUR

  • German
  • English